-
DSP Healthcare Fund Regular Growth
Equity healthcare
Overview ( as on 25/07/24 )
NAV
₹36.27
Last change
₹0.24 +0.01%
Fund Size (AUM)
2479.25 Cr
Performance
29.5% (5Y)
Fund Details
DSP Healthcare Fund Regular Growth
as of 25/07/24
AUM
2479.25 Cr
Expense Ratio
1.98 %
Benchmark
BSE Healthcare TR INR
ISIN
INF740KA1LD8
Fund Manager
Jay Kothari
Exit Load
0.5% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| DSP Healthcare Fund Regular Growth | 44.55% | 17.3% | 29.5% |
| BSE Healthcare TR INR | 43.76% | 13.19% | 23.55% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
12.5% |
Suven Pharmaceuticals Ltd |
9.38% |
Cipla Ltd |
8.28% |
Ipca Laboratories Ltd |
7.31% |
Lupin Ltd |
7.14% |
Alembic Pharmaceuticals Ltd |
5.03% |
Apollo Hospitals Enterprise Ltd |
4.65% |
Zydus Lifesciences Ltd |
4.49% |
Concord Biotech Ltd |
3.9% |
Procter & Gamble Health Ltd |
3.23% |
Sector Allocation
Healthcare |
98.22% |
Financial |
1.78% |
Asset Allocation
-
98%
Equity
-
2%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
28.95% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
29.5% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
27.91% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
27.91% (5Y)
-
-
Tata India Pharma & Healthcare Reg Gr
Equity healthcare-
Returns
-
25.83% (5Y)
-
-
Tata India Pharma & Healthcare RegIDCW-R
Equity healthcare-
Returns
-
25.83% (5Y)
-
